Vivanta Generics Sro Msn Labratories Private competitive analysis

Explore patent oppositions filed by Vivanta Generics Sro Msn Labratories Private against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 29, 2026
Patent NumberTitleApplicantOpposition Date
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISDec 6, 2022

Latest PTAB cases involving Vivanta Generics Sro Msn Labratories Private

Discover the latest PTAB cases involving Vivanta Generics Sro Msn Labratories Private, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Vivanta Generics Sro Msn Labratories Private with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 29, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
VIVANTA GENERICS SRO MSN LABRATORIES PRIVATE1 - - -
NOVARTIS6424 - 21